Attitudes of Older Adult Patients and Caregivers Towards Deprescribing of Medications in Ethiopia

References

• Barnett NL, Oboh L, Smith K. Patient-centred management of polypharmacy: a process for practice. Eur J Hosp Pharm. 2015;23:113–117. doi:10.1136/ejhpharm-2015-000762
   PubMedGoogle Scholar
• Guillot J, Maumus-robert S, Bezin J. Polypharmacy: a general review of definitions, descriptions and determinants. Therapies. 2020;75:407–416. doi:10.1016/j.therap.2019.10.001
   PubMed Web of Science ®Google Scholar
• Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82:583–623. doi:10.1111/bcp.12975
   PubMed Web of Science ®Google Scholar
• Jansen J, Naganathan V, Carter SM, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;353. doi:10.1136/bmj.i2893
   PubMedGoogle Scholar
• WHO Centre for Health Development (‎Kobe J). A glossary of terms for community health care and services for older persons. Kobe, Japan: WHO Centre for Health Development; 2004. Available from: https://apps.who.int/iris/handle/10665/68896. Accessed March 6, 2023.
   Google Scholar
• Tao L, Qu X, Gao H, Zhai J, Zhang Y, Song Y. Polypharmacy and potentially inappropriate medications among elderly patients in the geriatric department at a single-center in China. Medicine. 2021;100:1–8. doi:10.1097/MD.0000000000027494
   Web of Science ®Google Scholar
• Masnoon N, Shakib S, Kalisch-ellett L, Caughey GE. What is polypharmacy ? A systematic review of definitions. BMC Geriatr. 2017;230:1–10. doi:10.1186/s12877-017-0621-2
   Google Scholar
• Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;2018(9). doi:10.1002/14651858.CD008165.pub4
   Google Scholar
• Fick DM, Semla TP, Steinman M, et al. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.15767
   PubMed Web of Science ®Google Scholar
• O’mahony D, O’sullivan D, Byrne S, O’connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218. doi:10.1093/ageing/afu145
   PubMed Web of Science ®Google Scholar
• Kua CHH, Reeve E, Tan DS, et al. Patients’ and caregivers’ attitudes toward deprescribing in Singapore. J Gerontol A Biol Sci Med Sci. 2021;76(6):1053–1060. doi:10.1093/gerona/glaa018
   PubMed Web of Science ®Google Scholar
• Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370(9582):185–191. doi:10.1016/S0140-6736(07)61092-7
   PubMed Web of Science ®Google Scholar
• Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in Elderly Patients. Am J Geriatr Pharmacother. 2007;5:345–351. doi:10.1016/j.amjopharm.2007.12.002
   PubMedGoogle Scholar
• Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME. Kidney function, polypharmacy, and potentially inappropriate medication use in a community-based cohort of older adults. Drugs Aging. 2018;35(8):735–750. doi:10.1007/s40266-018-0563-1
   PubMed Web of Science ®Google Scholar
• Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350. doi:10.1136/bmj.h176
   Google Scholar
• Nwadiugwu MC. Frailty and the risk of polypharmacy in the older person: enabling and preventative approaches. J Aging Res. 2020;2020:1–6. doi:10.1155/2020/6759521
   Google Scholar
• Turk A, Wong G, Mahtani KR, et al. Optimising a person - centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review. BMC Med. 2022;297:1–18. doi:10.1186/s12916-022-02475-1
   Google Scholar
• Shrestha S, Poudel A, Cardona M, Steadman KJ, Nissen LM. Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis. Ther Adv Drug Saf. 2021;12:1–16. doi:10.1177/20420986211052343
   Web of Science ®Google Scholar
• Gillespie RJ, Harrison L, Mullan J. Deprescribing medications for older adults in the primary care context: a mixed studies review. Health Sci Rep. 2018;1(7):e45. doi:10.1002/hsr2.45
   PubMedGoogle Scholar
• Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100(1):32–38.
   PubMed Web of Science ®Google Scholar
• Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–834. doi:10.1001/jamainternmed.2015.0324
   PubMed Web of Science ®Google Scholar
• Triantafylidis LK, Hawley CE, Perry LP, Paik JM. The role of deprescribing in older adults with chronic kidney disease. Drugs Aging. 2018;35:973–984. doi:10.1007/s40266-018-0593-8
   PubMed Web of Science ®Google Scholar
• Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of attitudes toward deprescribing in older medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673–1680. doi:10.1001/jamainternmed.2018.4720
   PubMed Web of Science ®Google Scholar
• Shrestha SS, Giri R, Sapkota HP, et al. Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe. Ther Adv Drug Saf. 2021;12:1–11. doi:10.1177/20420986211019309
   Web of Science ®Google Scholar
• Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–747. doi:10.1111/bcp.12386
   PubMed Web of Science ®Google Scholar
• Sirois C, Ouellet N, Reeve E. Community-dwelling older people’s attitudes towards deprescribing in Canada. Res Soc Admin Pharma. 2017;13(4):864–870. doi:10.1016/j.sapharm.2016.08.006
   PubMed Web of Science ®Google Scholar
• Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544. doi:10.1136/bmjopen-2014-006544
   PubMed Web of Science ®Google Scholar
• Farrell B, Tsang C, Raman-wilms L, Irving H. What are priorities for deprescribing for elderly patients ? Capturing the voice of practitioners: a modified delphi process. PloS One. 2015;1–16. doi:10.1371/journal.pone.0122246
   Web of Science ®Google Scholar
• Gebreyohannes AS, Emayehu FD. Prevalence of polypharmacy and risks of potentially inappropriate medication use in the older population in a developing country: a systematic review and meta-analysis. Gerontology. 2021. doi:10.1159/000516075
   PubMed Web of Science ®Google Scholar
• Tegegn HG, Tefera YG, Erku DA, et al. Older patients’ perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital. BMJ Open. 2018;8(4):20590. doi:10.1136/bmjopen-2017-020590
   Web of Science ®Google Scholar
• Bhagavathula AS, Gebreyohannes EA, Fialova D. Prevalence of polypharmacy and risks of potentially inappropriate medication use in the older population in a developing country: a systematic review and meta-analysis. Gerontology. 2021;68:136–145. doi:10.1159/000516075
   PubMed Web of Science ®Google Scholar
• Reeve E, Low LF, Shakib S, Hilmer SN. Development and validation of the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33:913–928. doi:10.1007/s40266-016-0410-1
   PubMed Web of Science ®Google Scholar
• Chock YL, Wee YL, Gan SL, Teoh KW, Ng KY, Lee SWH. How willing are patients or their caregivers to deprescribe: a systematic review and meta-analysis. J Gen Intern Med. 2021;36(12):3830–3840. doi:10.1007/s11606-021-06965-5
   PubMed Web of Science ®Google Scholar
• Crutzen S, Abou J, Smits SE, et al. Older people’s attitudes towards deprescribing cardiometabolic medication. BMC Geriatr. 2021;366:1–12. doi:10.1186/s12877-021-02249-z
   Google Scholar
• Rochon PA, Petrovic M, Cherubini A, et al. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens. Lancet Healthy Longev. 2021;2:e290–e300. doi:10.1016/S2666-7568(21)00054-4
   PubMedGoogle Scholar
• Major GL, Mills A, Lowthian JA. Deprescribing attitudes of older adults receiving medication management support from home-based nurses. J Am Geriatr Soc. 2019;67(8):1756–1757. doi:10.1111/jgs.16015
   PubMed Web of Science ®Google Scholar
• Díaz Planelles I, Navarro-Tapia E, García-Algar Ó, Andreu-Fernández V. Prevalence of potentially inappropriate prescriptions according to the new STOPP/START criteria in nursing homes: a systematic review. Healthcare. 2023;422:1–25. doi:10.3390/healthcare11030422
   Google Scholar
• Morin L, Laroche ML, Texier G, Johnell K. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17:862.e1–862.e9. doi:10.1016/j.jamda.2016.06.011
   PubMed Web of Science ®Google Scholar
• Kua CH, Mak VSL, Lee SWH. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta- analysis. J Am Med Dir Assoc. 2019;20:362–372. doi:10.1016/j.jamda.2018.10.026
   PubMed Web of Science ®Google Scholar
• Krustev T, Milushewa P, Tachkov K. Impact of polypharmacy, drug-related problems, and potentially inappropriate medications in geriatric patients and its implications for Bulgaria—narrative review and meta-analysis. Front Public Health. 2022;743138:1–12. doi:10.3389/fpubh.2022.743138
   Google Scholar
• Liew NY, Chong YY, Yeow SH, Kua KP, Saw PS, Lee SWH. Prevalence of potentially inappropriate medications among geriatric residents in nursing care homes in Malaysia: a cross-sectional study. Int J Clin Pharm. 2019;41(4):895–902. doi:10.1007/s11096-019-00843-1
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85(1):86–88. doi:10.1038/clpt.2008.224
   PubMed Web of Science ®Google Scholar
• Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharma Pract Res. 2003;33:323–328. doi:10.1002/jppr2003334323
   Google Scholar
• Achterhof AB, Rozsnyai Z, Reeve E, et al. Potentially inappropriate medication and attitudes of older adults towards deprescribing. PLoS One. 2020;15(10):1–14. doi:10.1371/journal.pone.0240463
   Web of Science ®Google Scholar
• Delara M, Murray L, Jafari B, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;601:1–12. doi:10.1186/s12877-022-03279-x
   Google Scholar
• Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–1196. doi:10.1080/14740338.2018.1546841
   PubMed Web of Science ®Google Scholar
• Oktora MP, Yuniar CT, Amalia L, Abdulah R, Hak E, Denig P. Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes (T2D) in Indonesia: a cross-sectional survey study. BMC Geriatr. 2023;23(21):1–11. doi:10.1186/s12877-022-03718-9
   PubMedGoogle Scholar
• Weir KR, Ailabouni NJ, Schneider CR, Hilmer SN, Reeve E. Consumer attitudes towards deprescribing: a systematic review and meta-analysis. J Gerontol. 2022;77(5):1020–1034. doi:10.1093/gerona/glab222
   Google Scholar
• Aoki T, Yamamoto Y, Ikenoue T, Fukuhara S. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531–537. doi:10.1007/s11096-019-00797-4
   PubMed Web of Science ®Google Scholar
• Rozsnyai Z, Jungo KT, Reeve E, et al. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey. BMC Geriatr. 2020;435:1–11. doi:10.1186/s12877-020-01843-x
   Google Scholar
• Kua KP, Saw PS, Lee SWH. Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study. Int J Clin Pharm. 2019;41(3):793–803. doi:10.1007/s11096-019-00829-z
   PubMed Web of Science ®Google Scholar
• Rakheja B, Sirois C, Ouellet N, Roux B, Laroche ML. Attitudes toward deprescribing in older adults and caregivers: a survey in Quebec, Canada. J Appl Gerontol. 2022;41(5):1376–1384. doi:10.1177/07334648211069553
   PubMed Web of Science ®Google Scholar
• Edelman M, Jellema P, Hak E, Denig P, Blanker MH. Patients’ attitudes towards deprescribing alpha-blockers and their willingness to participate in a discontinuation trial. Drugs Aging. 2019;36(12):1133–1139. doi:10.1007/s40266-019-00712-6
   PubMed Web of Science ®Google Scholar
• Galazzi A, Lusignani M, Chiarelli MT, et al. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. Int J Clin Pharm. 2016;38(2):454–461. doi:10.1007/s11096-016-0279-4
   PubMed Web of Science ®Google Scholar
• Scott S, Clark A, Farrow C, et al. Attitudinal predictors of older peoples’ and caregivers’ desire to deprescribe in hospital. BMC Geriatr. 2019;19(108). doi:10.1186/s12877-019-1127-x
   Google Scholar
• Bužančić I, Dragović P, Pejaković TI, Markulin L, Ortner-Hadžiabdić M. Exploring patients’ attitudes toward deprescribing and their perception of pharmacist involvement in a European country: a cross-sectional study. Patient Prefer Adherence. 2021;15:2197–2208. doi:10.2147/PPA.S323846
   PubMed Web of Science ®Google Scholar
• Lukacena KM, Keck JW, Freeman PR, Harrington NG, Huffmyer MJ, Moga DC. Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists. Ther Adv Drug Saf. 2022;13:204209862211164. doi:10.1177/20420986221116465
   Web of Science ®Google Scholar
• Martinez AI, Spencer J, Moloney M, Badour C, Reeve E, Moga DC. Attitudes toward deprescribing in a middle-aged health disparities population. Res Soc Admin Pharma. 2020;16(10):1502–1507. doi:10.1016/j.sapharm.2020.02.014
   PubMed Web of Science ®Google Scholar
• Oktora MP, Edwina AE, Denig P. Differences in older patients’ attitudes toward deprescribing at contextual and individual level. Front Public Health. 2022;795043:1–7. doi:10.3389/fpubh.2022.795043
   Google Scholar
• Howard DH, Sentell T, Gazmararian JA. Impact of health literacy on socioeconomic and racial differences in health in an elderly population. J Gen Intern Med. 2006;21(8):857–861. doi:10.1111/j.1525-1497.2006.00530.x
   PubMed Web of Science ®Google Scholar
• Tang C, Wu X, Chen X, Pan B, Yang X. Examining income-related inequality in health literacy and health-information seeking among urban population in China. BMC Public Health. 2019;19(1). doi:10.1186/s12889-019-6538-2
   Google Scholar
• Ibrahim K, Cox NJ, Stevenson JM, Lim S, Fraser SDS, Roberts HC. A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr. 2021;21:258. doi:10.1186/s12877-021-02208-8
   PubMed Web of Science ®Google Scholar
• Hoel RW, Giddings Connolly RM, Takahashi PY. Polypharmacy management in older patients. Mayo Clin Proc. 2021;96(1):242–256. doi:10.1016/j.mayocp.2020.06.012
   PubMed Web of Science ®Google Scholar
• Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. J Am Geriatr Soc. 2015;63(11):2227–2246. doi:10.1111/jgs.13702
   PubMedGoogle Scholar
• Kennie-Kaulbach N, Cormier R, Kits O, et al. Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: an examination using behavior change frameworks. Med Access. 2020. doi:10.1177/2399202620922507
   Google Scholar
• Lundby C, Glans P, Simonsen T, et al. Attitudes towards deprescribing: the perspectives of geriatric patients and nursing home residents. J Am Geriatr Soc. 2021;69(6):1–11. doi:10.1111/jgs.17054
   Web of Science ®Google Scholar
• Graabæk T, Lundby C, Ryg J, Søndergaard J, Pottegård A, Nielsen DS. “I simply don’t know, because I don’t know which drugs I get”: perspectives on deprescribing among older adults with limited life expectancy and their relatives. Basic Clin Pharmacol Toxicol. 2021;128(1):115–127. doi:10.1111/bcpt.13476
   PubMed Web of Science ®Google Scholar